Li Run, Wang Manliu, Li Jingyi, Zhu Li, Xie Xinfang, Wang Hui, Zhang Xu, Tian Wenmin, Zhang Yong, Dong Yaping, Zan Jincan, Li Hongyu, Zhang Yuemiao, Zhou Xujie, Shi Sufang, Shu Chutian, Liu Lijun, Jin Jing, Lv Jicheng, Zhang Hong
Renal Division, Key Laboratory of Renal Disease, Ministry of Health of China, Peking University Institute of Nephrology, Peking University First Hospital, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
J Am Soc Nephrol. 2025 Jan 1;36(1):60-72. doi: 10.1681/ASN.0000000000000465. Epub 2024 Aug 22.
We generated a transgenic mouse model expressing the human IgA1 heavy chain, which has a hinge region with rich -linked glycosylation. After inflammatory stimulation, the mouse model showed elevated galactose-deficient IgA1 levels in the serum. Coupled with complement H factor mutant, the mice model exhibited glomerular lesions, associated with hematuria and albuminuria like IgA nephropathy.
IgA nephropathy is the most common primary glomerulonephritis worldwide, and there is emerging evidence linking galactose-deficient IgA1 (Gd-IgA1) to the pathogenesis of the disease. However, mouse models that can be used to study Gd-IgA1's origin of production, biochemical characteristics, and immune reactivity are lacking.
We generated a humanized IgA1 mouse model with transgenic expression of the human gene from the mouse chromosomal locus of IgA heavy chain. The mice were crossed with complement factor H heterozygous mutant (FH) to generate FH mice. mice were exposed to different levels of environmental pathogens in the first 4 months, as housed in germ-free, specific pathogen–free, or conventional environments. In addition, wild-type C57BL/6J mice, mice, and FH mice were inoculated with cell wall extract (LCWE) mixed with complete Freund's adjuvant (CFA) at 2 months of age to develop a mouse model of IgA nephropathy.
Elevated levels of human IgA1 in blood circulation and mucosal sites were observed in mice from exposure to pathogens. Compared with buffer-treated control mice, LCWE plus CFA-treated mice had moderately elevated levels of circulating human IgA1 (by one-fold) and human IgA1 immune complexes (by two-fold). Serum Gd-IgA1 levels increased four-fold after LCWE treatments. Analyses of the -glycopeptides of the IgA1 hinge region confirmed hypogalactosylation of IgA1, with the variety of the glycoforms matching those seen in clinical samples. Furthermore, LCWE induced persistent IgA1 and C3 deposition in the glomerular mesangial areas in association with mesangial expansion and hypercellularity, which are frequently observed in IgA nephropathy biopsies. The IGHA1FH mice stimulated with LCWE and CFA developed albuminuria and hematuria.
We observed elevated plasma Gd-IgA1 levels with kidney deposition of IgA1 in the mice after LCWE and CFA. In conjunction with factor H mutation, the mice exhibited severe glomerular alterations, associated with hematuria and albuminuria in resemblance of clinical IgA nephropathy.
我们构建了一种表达人IgA1重链的转基因小鼠模型,该重链具有富含O-连接糖基化的铰链区。炎症刺激后,该小鼠模型血清中半乳糖缺陷型IgA1水平升高。与补体H因子突变体杂交后,该小鼠模型出现肾小球病变,伴有血尿和蛋白尿,类似于IgA肾病。
IgA肾病是全球最常见的原发性肾小球肾炎,越来越多的证据表明半乳糖缺陷型IgA1(Gd-IgA1)与该疾病的发病机制有关。然而,缺乏可用于研究Gd-IgA1产生来源、生化特性及免疫反应性的小鼠模型。
我们构建了一种人源化IgA1小鼠模型,其通过IgA重链的小鼠染色体位点转基因表达人基因。将该小鼠与补体因子H杂合突变体(FH)杂交以产生FH小鼠。在最初4个月,将小鼠置于无菌、无特定病原体或常规环境中,使其暴露于不同水平的环境病原体。此外,在2月龄时,给野生型C57BL/6J小鼠、该小鼠及FH小鼠接种与完全弗氏佐剂(CFA)混合的肺炎链球菌细胞壁提取物(LCWE),以建立IgA肾病小鼠模型。
暴露于病原体的该小鼠血液循环和黏膜部位的人IgA1水平升高。与缓冲液处理的对照小鼠相比,LCWE加CFA处理的小鼠循环中人IgA1水平适度升高(1倍),人IgA1免疫复合物水平升高(2倍)。LCWE处理后血清Gd-IgA1水平增加4倍。对IgA1铰链区的O-糖肽分析证实了IgA1的低半乳糖基化,糖型种类与临床样本中所见相符。此外,LCWE诱导IgA1和C3持续沉积于肾小球系膜区,伴有系膜扩张和细胞增多,这在IgA肾病活检中常见。用LCWE和CFA刺激的IGHA1FH小鼠出现蛋白尿和血尿。
我们观察到LCWE和CFA处理后该小鼠血浆Gd-IgA1水平升高且IgA1在肾脏沉积。与因子H突变相结合,这些小鼠表现出严重的肾小球改变,伴有血尿和蛋白尿,类似于临床IgA肾病。